Publication | Closed Access

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial

Disease ProgressionNeurological DisorderMedicineNew Disease ActivityClinical TrialsNeurologyNon-inferiority TrialMultiple SclerosisNeurorehabilitationNeuroimmunology